Stories related to Science

Diagnostics ABC: all you need to know about diagnostics terms

How much do you know about diagnostics terms? Here’s what you need to know to shine in every discussion about testing.

Blending a new approach to genetic testing for cancer

For better insights into cancer tumour genetic mutations, scientists enlisted the aid of an unusual tool - a kitchen blender.

What is IBD?

IBD is a group of complex, chronic conditions, characterised by prolonged inflammation of the gastrointestinal tract, which can have a long-term impact on a patient's quality of life.

James Sabry on the future of medicine

Roche’s Global Pharma Partnering leader talks about the nature of different diseases and future therapies

Roche at ASCO 2020

Elena Bernedo Arzac, Head of Oncology, GPS at Roche Pharmaceuticals: Advancing the science through our computer screens.

COVID-19: How antibody tests help to detect those already infected with SARS-CoV-2

SARS CoV-2 infections often go without symptoms. Antibody tests can identify individuals who have been exposed to the virus. Learn how this works.

Turning the tide of COVID-19

Widespread, reliable testing can help the world chart a course back to normal life.

COVID-19 and the mysterious world of antibodies

Timothy Tellinghuisen, Head of Virology Discovery, explains why understanding antibodies could hold the key in tackling COVID-19 and other pandemics.

COVID-19: How molecular testing detects SARS-CoV-2

Testing is the best way to be sure that someone is positive for the SARS-CoV-2 infection. Learn how testing using PCR works.

The double risk of vulnerable populations and COVID-19

The elderly and those with mental diseases are the largely silent and sometimes overlooked victims of the pandemic.

Are men more affected by the novel coronavirus than women?

Roche neuroscientist Antonella Santuccione Chadha explores how sex and gender differences in the disease can help propel precision medicine forward.

Researching the coronavirus in the search for solutions

Head of Infectious Diseases at Roche Pharma Early Research & Development, John Young shares his insights on the biology of covid-19 and outlook on future cures.

Working with urgency, passion and purpose

Amidst the unprecedented global pandemic COVID-19, we bravely continue to work to ensure that patients receive our medicines and solutions as fast as possible.

Meet our Roche pRED scientists

Learn more about our scientists and how they are tackling many devastating diseases.

Amidst the unknowns, some tips to stay safe against COVID-19

Infectious disease expert Klaus Kuhlbusch shares his experience working with the flu and how it differs from coronavirus.

COVID-19: Containing and conquering a global health threat

Broad access to reliable coronavirus testing is essential to an outbreak containment strategy.

An iceberg of lost memories

Geoffrey Kerchner explains why Alzheimer’s is like an iceberg; most disease activity happens slowly below the surface, before you see the first symptoms.

Liver cancer

HCC is known as a ‘silent killer’ as the symptoms often appear too late for curative treatments. Learn more about the signs, symptoms and risk factors.

Discussing multiple sclerosis through storytelling

Hear from Annarita and her family about how she used storytelling to explain the impact of the progressive nature of multiple sclerosis.

Roche continues to lead the fight against cancer together

This World Cancer Day, learn how we are working together with our partners, including the UICC, to transform the lives of people living with cancer.

Tip of the iceberg: the hidden impact of Alzheimer’s disease

Caring for people with Alzheimer’s disease has a huge economic and emotional impact. Learn about the intangible costs and Freeha’s experience with her father.

New approaches to understand multiple sclerosis

MS is a disease of the central nervous system, estimated to affect 2.3 million people worldwide.

Roche Diagnostics product portfolio

Roche Diagnostics is transforming the way diseases can be prevented, diagnosed and monitored.

Partnering to drive innovation in cancer immunotherapy

We’re partnering with many different stakeholders to find the most effective way for the immune system to identify and kill cancer cells.

Understanding multiple sclerosis as a progressive disease

World-leading neurologists share their opinion on MS as a progressive disease from the start.

Cancer genomic testing – Debbie Rhea’s story

Learn about the importance of genomic testing in treating cancer, and hear from patient; Debbie Rhea about the real-world impact it can have.

Cancer genomic testing – Jamal Tamer’s story

Learn about the importance of genomic testing in treating cancer, and hear from patient; Jamal Tamer about the real-world impact it can have.

Haematology: It’s in our blood

Learn more about this complex and challenging area of medicine, and how Roche is redefining treatment for people with diseases of the blood.

Every Cancer Is Unique. Let’s Treat It That Way.

Every cancer is unique. Discover how genomic testing can reveal mutations in a cancer tumour that can guide personalised treatment decisions.

HIV - From life ending to life changing

40 years of progress in HIV/AIDS diagnostics.

Hunting for solutions

Find out how Roche is harnessing the latest technology to treat Huntington’s disease.

Our Roche Innovation Centers

Our organisation has more than 2,200 scientists at seven Roche Innovation Centers spanning each major continent

Lung Cancer Awareness Month: An evolution

By continuing to challenge the stigma associated with lung cancer, we hope to drive improved outcomes for patients this November and beyond.

Autism Spectrum Disorder: A journey with unique challenges

Kathy Hyde hopes that telling her son’s story will help increase understanding of the challenges faced by individuals with autism spectrum disorder.

Will genomics revolutionise the future of medicine?

Joanne Hackett talks about genomics, healthcare, big data and people’s hesitation to share medical data.

Will quantum computers solve the problems of the future?

Martin Strahm talks about the idea, the potential and the limitations of quantum computers.

Shaping the future of cancer care

Combining science, partnerships and analytics in the fight against cancer.

Levi Garraway: A passion for purpose

Levi Garraway has officially started his new leadership role as Roche’s chief medical officer. Read Garraway’s story.

Our response to cancer always starts with the science

Targeting cancer demands a deep understanding of its complexities. Our researchers have the freedom to explore cutting-edge science & technology to achieve this.

Roche at ESMO 2019

Learn about our activities at ESMO this year, and how we are working towards improved outcomes for patients.

Taking a stand against cancer

All you need to know about the people and the important work at Roche Pharma Research and Early Development (pRED) Oncology as we discover the future in cancer care.

Open-sourcing health

Effective and purposeful collaborations will allow us to do much more together, to be much smarter together, than we can be alone.

Learn more about the work of pRED oncology at Roche

Christian Rommel, Global Head of pRED Oncology, gives his perspectives on cancer research in Roche and beyond.

Understanding geographic atrophy

Geographic atrophy, an advanced form of age-related macular degeneration (AMD), can have a devastating impact on vision.

Understanding retinal vein occlusion

Learn more about retinal vein occlusion (RVO) a serious eye disease that affects the retina, a part of the eye that sends information to the brain enabling sight.

Understanding neuromyelitis optica spectrum disorder

Neuromyelitis optica spectrum disorder (NMOSD) is a rare, lifelong and debilitating autoimmune disease of the central nervous system (CNS) that primarily damages the optic nerve and the spinal cord.

Understanding myopic choroidal neovascularisation

Myopic choroidal neovascularisation (mCNV) is a complication of severe short-sightedness that can lead to blindness.

Understanding diabetic eye disease

If you have diabetes, it's important to know what is going on in the back of your eyes. Diabetic eye disease may lead to vision loss.

Seeing the unseen with artificial intelligence

AI could change the way ophthalmologists diagnose eye conditions like diabetic macular edema.

Women’s health

No matter what stage of life or part of the world a woman is in, knowledge is power.

Understanding neovascular age-related macular degeneration

Learn about neovascular age-related macular degeneration, a leading cause of vision loss for people over 60.

The value of diagnostics in heart failure management

Heart failure affects millions of people and despite improvement in care, management remains challenging. Biomarkers can help patients at every stage of care.

Calculating the unimaginable

Quantum computers promise to offer computing power far beyond anything we can imagine.

Just the other day, I realised I could open the fridge again

Conversations with people with SMA and their families

Healthy liver, healthy lives

The liver is your body’s chemical processing plant, a powerhouse crucial to remove toxins; but liver cancer is on the rise. Learn what we can do to change this.

Taking control of IPF: A tale of two perspectives

Rainer, who was diagnosed with idiopathic pulmonary fibrosis (IPF) after two stressful years of uncertainty, tells his story on living with IPF alongside expert advice from his doctor.

Understanding the role of the microbiome in IBD

Unlocking the mysteries of the gut’s unique and diverse environment of micro-organisms to help improve patient treatment outcomes.

Roche in Haemophilia

Find out more about haemophilia A and how Roche is developing novel approaches to hopefully advance the management of this serious disorder.

A conversation with Roland Beckmann, inventor of the DutaMab technology

Interview with Dutalys co-founder and inventor of the DutaMab technology platform, Roland Beckmann, on his invention and journey founding a biotech.

Scaling up cancer care

Personalised healthcare is becoming a reality across the continuum of cancer care, from the nanoscale to the national.

Our philanthropic journey

Over 100 years of partnerships to make a sustainable difference for communities in which we operate and beyond.

How machine learning is transforming healthcare

Advanced analytics provide novel insights that could help to tackle some of the most complex problems in healthcare.

Tumour-agnostic treatments: A radical new approach to tackling cancer

Learn how tumour-agnostic approaches have the potential to change the way we diagnose, and treat, cancer in the future.

Piecing together the puzzle of IBD

Read how we are approaching personalised healthcare in IBD to support individualised care for people living with ulcerative colitis and Crohn’s disease.

An introduction to personalised healthcare for the eye

Insights on how personalised healthcare can bring meaningful benefits to patients with retinal diseases

Inflammatory bowel diseases

We aim to provide the most meaningful outcomes for patients with ulcerative colitis and Crohn’s disease. Learn about the current initiatives in IBD care.

Roche's personalised approach in IBD

Compare today's approach in IBD with the ideal future

Life with NMOSD: Staying who you are with a rare disease

“Do not take life for granted. Take every moment in.”

Roche in Neuroscience & Rare Disease: Preserving what makes people who they are

Our mission is rooted in our formula: follow the science to preserve what makes people who they are.

Getting closer to cancer research's holy grail

Combining clinical and genomic data to advance personalised healthcare.

Shedding light on progression in MS

How Roche is paving the way for better understanding of MS disease progression and monitoring.

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

Measuring what matters

How Patient-Reported Outcomes are helping to redefine haemophilia care

What is Personalised Healthcare?

Personalised healthcare is about providing the right treatment for the right patient. Fitting treatments to patients has always been the objective of medicine, of course. But only recent advances in science and technology have made this possible.

Roche in rare diseases

Find out what makes a rare disease rare and who is affected.

Becoming EverGreener

Becoming EverGreener

Partnering to fulfill the promise of personalised healthcare

The promise of personalised healthcare is a simple one: finding the right treatment for every patient. Through strategic partnerships, Roche is committed to fulfilling that promise.

Hepatitis B - Aiming for cure of a killer

Hepatitis B is responsible for more than 800,000 deaths a year. Roche is working on a cure.

How decades of blood cancer research is paying off

We explore how a growing understanding of the biology of blood cancers is transforming the development and delivery of treatments for patients.

Would you share your health data?

Most patients are willing to share their data to contribute to medical progress, but they want transparency.

Ophthalmology

We are focused on saving people’s eyesight from the leading causes of vision loss through pioneering therapies.

Targeting liver cancer in China

An interview with Professor Ren.

Supporting people with MS: A nurse’s story

Learn how specialist MS nurse Anna Cunningham, helps people with MS manage their condition

Beating lung cancer – one gene at a time

How gene targeting might transform the lives of patients with rare forms of lung cancer

A breast cancer journey of hope

Science and the City: Basel

Basel grew up with the chemical-pharmaceutical industry, and the chemical-pharmaceutical industry grew up with Basel.

Striking back at stroke risk

Why less is more in atrial fibrillation management

The measure of you

Explore how digital biomarkers are changing the way we understand health.

Getting over the ups and downs

Dr Gallia Levy, Associate Group Medical Director at Roche, shares her perspective on the need for sustained bleeding protection in haemophilia A.

Meet Amrita, Bioinformatics Research Leader at Pleasanton, CA

"The sky is the limit when it comes to learning about new domains and extending your skills."

The NT-proBNP Story

Biomarkers play a crucial role in Roche’s commitment to personalised healthcare. To find them, we rely on the promising research of our external partners.

Haemophilia A to Z

Learn about haemophilia A through the eyes of patients, caregivers and experts.

​Meet Cheng-Yuk, Principal Scientist I at Pleasanton, CA

It is truly a diversified environment. From the interdisciplinary education to the multi-cultural workforce, I strongly believe our collective experiences and passion will drive the innovation engine to develop the next meaningful diagnostics solution for patients.

Engineering bispecific antibodies

We’re engineering complex molecules that hit more than one target at once to address retinal diseases.

Relapsing multiple sclerosis: Unravelling the maze

Explore how the patient pathway for people living with relapsing MS has changed over the past 20 years.

Sustainability at Roche: Our impact

Engaging with stakeholders is crucial to create sustainable value. Stakeholder engagement enables us to jointly develop solutions.

Better together: Helping one million people with diabetes

Ask anybody with diabetes: managing it is time consuming, exhausting and very annoying.

Of bonds and benefits

Two made-in-Japan collaborations strengthen both Roche and its partners.

Bringing patient support to a rare disease

Learn how we are breaking down barriers that prevent patients from joining clinical trials for spinal muscular atrophy.

Our Approach to Cancer Immunotherapy

Roche are leading in cancer immunotherapy through innovative research, including immune profiling, with the goal to develop treatment tailored to individuals.

Unconventional wisdom

How challenging the status quo led to the discovery of the B cell as a new target in MS.

Roche at J.P. Morgan Healthcare Conference

Collaborating to drive the future of personalised healthcare

Always trying to err on the side of drug safety

Keeping its medicines safe for the people who need them is at the core of our remit.

Rising to the challenge

As multidrug resistant strains of bacteria are posing a growing threat to human health worldwide, our scientists are working hard on the next generation of antibiotics and diagnostic tests.

Every person is unique. So is every cancer.

Advances in genomics are helping physicians to understand patients’ unique cancer types and to identify whether targeted therapy options are available for them.

Science and the City: Munich

Munich may be known as a world cultural city, but it also now a driving force in driving innovation in healthcare.

Changing the perspective on lung cancer: a story of hope and survival

How does understanding each lung cancer’s unique footprint set you on the right path for a promising new future? Find out...

Busting myths in lung cancer

How much do you really know about lung cancer? Our interactive flashcards bust some common myths about lung cancer.

Expecting more for people with PPMS

Dr. Jerome de Seze, explains how recent clinical advances mean more and more people are being diagnosed with PPMS.

MS measurements explained

How we define the ways in which multiple sclerosis can be measured.

Primary progressive MS: Different perspectives

Dr. de Seze and Craig Milverton, who lives with primary progressive multiple sclerosis (PPMS), share their experiences managing and living with this form of MS.

A future in mind – rising to the challenge of Alzheimer’s

Discover how we are advancing towards treatments that can stop, slow or prevent, and ultimately improve the care available for people with Alzheimer’s disease.

Be part of Science and the City in Basel

Watch Nobel Prize winner Paul Nurse and Roche scientist Bryn Roberts on our live streaming. Get more information here.

The realities of pursuing the cure for cancer

Cindy Perettie, our Global Head of Oncology Strategy, provides her personal perspective on the challenges of leading the cure for cancer.

Forms of multiple sclerosis: What are the similarities and differences?

The underlying biology of multiple sclerosis is similar for everyone, but its course and symptoms vary from person to person. Explore the similarities and differences between two forms of MS.

Lymphoma: Know the facts

Lymphoma is one of the most prevalent forms of blood cancer. Click on our interactive flashcards to find out some key facts on lymphoma we all should know.

Cancer immunotherapy biomarkers

Biomarkers continue to play a critical role in the development of personalised healthcare, particularly in cancer.

Smart technology speeds up development of antibiotics

Roche and British biotechnology company Discuva are collaborating to develop new classes of antibiotics for the treatment of multidrug-resistant bacteria.

Heart failure: the role of biomarkers in disease management

Heart failure can have a great impact on people’s live. Biomarkers can support physicians to make informed decisions as to the best course of care to patients.

Fighting viral hepatitis

Despite the burden it places on communities across the world, hepatitis appears to have been largely ignored as a public health concern

A little-known virus that can cause big problems

Most people can spend their entire lives not knowing they’ve been infected with CMV. But for transplant patients, this quiet invader can be life-threatening

Improving outcomes for people with multiple sclerosis

The London School of Economics “International MultiPlE Sclerosis Study” explores the need for policy change and better outcomes for people with MS.

Meet Cordula

Roche as an employer is providing a truly people-focused working environment. I will never forget how impressed I was when I joined Roche and became aware of the passion and engagement in the work of each and every colleague.

From “magic bullets” to new generation antibodies

With today's health challenges, medical progress is more important than ever. Therapeutic antibodies are addressing the complexity of targeting diseases with unmet medical need.

The role of HPV in cervical cancer

Everything you need to know about HPV infections and the link between HPV and cervical cancer.

What is multiple sclerosis?

MS is usually thought of as a single disease, but its course and symptoms vary from person to person.

Fighting antimicrobial resistance with diagnostics

Antimicrobial resistance is a global and continuously raising global health challenge. Here’s what we are doing to address this problem.

Facts about bladder cancer

Bladder cancer is one of the top ten most common cancers in the world.

Beyond the immunity cycle

Roche’s scientists are leading pioneers in immune biology and cancer research, which is resulting in innovative and personalised treatment options in cancer.

Lung cancer

Approximately 1.8 million people develop lung cancer every year. Can new diagnostic tools deliver earlier diagnosis and smarter treatment choices?

Roche in neuroscience

Roche Neuroscience addresses areas of high unmet medical need with no approved, effective or safe medicines. Learn about our approach.

Organs-on-a-Chip technology

Tiny labs made of plastic simulate the human body- the Organs-on-a-Chip technology shows new approaches to obtain human-relevant information on a potential drug.

Creating value through partnerships

Partnering builds on our culture, one in which we listen to a potential partner and structure a collaboration that meets both parties’ needs.

Ovarian cancer treatment advances over time – what’s next?

Take a look at the advances in ovarian cancer treatment over time and what the future holds for women with this disease.

Roche at the American Society of Hematology Annual Meeting

We presented new data on medicines for various blood cancers and blood disorders at the 2016 American Society of Hematology Annual Meeting.

Spotlight on comprehensive genomic profiling

Comprehensive genomic profiling provides valuable information that can help determine the best possible treatment for each patient.

Cancer immunotherapy

As our understanding of the immune system and tumour biology expands, so does our hope for developing treatments that may change people’s live.

Discover history’s most popular poster and its impact on how we see the world

The chart measuring visual acuity is the most popular poster in history.

The complexities of lymphoma: The importance of subtypes

With more than 90 subtypes, non-Hodgkin lymphoma is a complex group of diseases. Read this article to learn more.

Light bulb moments in MS

A journey of discovery and diagnosis; looking back at the history of multiple sclerosis

Engineered for treatment success: Cytokine Fusion Proteins

Cytokine fusion proteins stimulate the immune system with high specificity and tolerability and could be a transformative approach to cancer treatment.

Clinical trials

Clinical trials are essential to providing the scientific data required to determine whether new drugs, diagnostics or procedures are both safe and effective when used to diagnose and treat people.

Light bulb moments in oncology

15 of the biggest advances in cancer treatment to date.

Excellence in science

pRED scientists pursue excellence. Patients are waiting, so by pushing boundaries pRED scientists make breakthroughs every day.

9 things you may not know about cancer

Interesting facts about the world’s biggest health challenge.